Shiwen Peng Selected Research

Human papillomavirus type 16 oncogene protein E7

7/2011	Control of cervicovaginal HPV-16 E7-expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting agents.
4/2007	HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shiwen Peng Research Topics

Disease

40	Neoplasms (Cancer) 01/2022 - 08/2004
9	Infections 01/2018 - 05/2004
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 04/2007
5	Papillomavirus Infections 01/2018 - 08/2004
3	Uterine Cervical Dysplasia 01/2021 - 01/2009
3	Vaccinia 01/2021 - 02/2016
3	Carcinogenesis 10/2012 - 10/2007
2	Squamous Cell Carcinoma of Head and Neck 04/2022 - 01/2022
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 10/2007
2	Ovarian Neoplasms (Ovarian Cancer) 09/2018 - 12/2013
2	Recurrent respiratory papillomatosis 01/2018 - 11/2010
2	Multiple Myeloma 01/2015 - 12/2013
1	Carcinoma (Carcinomatosis) 01/2022
1	Mouth Neoplasms (Oral Cancer) 09/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2021
1	Ascites 09/2018
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Papilloma (Papillomatosis) 01/2017
1	Oropharyngeal Neoplasms 01/2017
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2015
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2015
1	Melanoma (Melanoma, Malignant) 02/2012
1	Shock 01/2009
1	Amyloidosis 10/2007
1	Alzheimer Disease (Alzheimer's Disease) 10/2007
1	Spontaneous Remission 04/2007
1	Squamous Intraepithelial Lesions 04/2007
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2007

Drug/Important Bio-Agent (IBA)

20	DNA VaccinesIBA 09/2021 - 08/2004
14	AntigensIBA 04/2021 - 05/2004
13	Proteins (Proteins, Gene)FDA Link 09/2021 - 01/2009
12	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2007
12	VaccinesIBA 04/2021 - 05/2004
7	Papillomavirus Vaccines (HPV Vaccines)IBA 09/2021 - 07/2011
6	A-Form DNA (A-DNA)IBA 01/2021 - 05/2004
6	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 01/2009
6	Therapeutic UsesIBA 01/2018 - 04/2007
5	Oncogene Proteins (Oncogene Protein)IBA 04/2021 - 01/2009
5	CalreticulinIBA 01/2017 - 08/2004
4	UbiquitinIBA 01/2020 - 01/2011
3	HLA-A2 Antigen (HLA A2 Antigen)IBA 04/2022 - 09/2021
3	EpitopesIBA 01/2022 - 04/2007
3	LuciferasesIBA 01/2018 - 11/2007
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2015 - 05/2005
3	Bortezomib (Velcade)FDA Link 01/2015 - 01/2009
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2014 - 10/2007
2	TransposasesIBA 09/2021 - 01/2018
2	Immune Checkpoint InhibitorsIBA 04/2021 - 01/2021
2	PiperidonesIBA 01/2020 - 12/2013
2	RA190IBA 01/2020 - 12/2013
2	Neutralizing AntibodiesIBA 08/2015 - 01/2015
2	FurinIBA 08/2015 - 01/2014
2	Histone Deacetylase InhibitorsIBA 01/2015 - 01/2009
2	GPI0100IBA 01/2015 - 02/2009
2	Peptides (Polypeptides)IBA 02/2014 - 07/2011
2	CytokinesIBA 03/2013 - 07/2011
2	vadimezanIBA 07/2011 - 03/2011
2	Human papillomavirus type 16 oncogene protein E7IBA 07/2011 - 04/2007
2	Small Interfering RNA (siRNA)IBA 08/2008 - 04/2007
1	chloroacetamideIBA 01/2020
1	NitrogenIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2018
1	Firefly LuciferasesIBA 09/2018
1	Immune Sera (Antisera)IBA 01/2018
1	IntegrinsIBA 01/2018
1	18 16 11 Types 6 Human Papillomavirus Recombinant Vaccine Quadrivalent (Gardasil)FDA Link 01/2018
1	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 02/2016
1	Pharmaceutical PreparationsIBA 01/2015
1	SaponinsIBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	CarrageenanIBA 01/2014
1	Messenger RNA (mRNA)IBA 03/2013
1	Tumor Viral Antigens (Large T Antigen)IBA 02/2012
1	OvalbuminIBA 07/2011
1	Chloroquine (Aralen)FDA LinkGeneric 01/2011
1	ErbB Receptors (EGF Receptor)IBA 11/2010
1	Peptide Hydrolases (Proteases)FDA Link 10/2010
1	propionamideIBA 10/2010
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2009
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2009
1	Vorinostat FDA Link 01/2009
1	Proteasome InhibitorsIBA 01/2009
1	trichostatin A (A 300)IBA 01/2009
1	EnzymesIBA 10/2007
1	Amyloid (Amyloid Fibrils)IBA 10/2007
1	Aspartic Acid ProteasesIBA 10/2007
1	HLA-DQB1 antigen (HLA DQB1)IBA 04/2007
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 02/2007
1	Immunodominant EpitopesIBA 08/2004

Therapy/Procedure

8	Immunotherapy 01/2022 - 02/2007
4	Therapeutics 01/2015 - 10/2007
1	Intravaginal Administration 03/2015
1	Drug Therapy (Chemotherapy) 01/2015
1	Radiotherapy 02/2014
1	Intramuscular Injections 09/2009